11/14/2024
3:04 PM | PFM Health Sciences, LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
10:54 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
8:37 AM | Adage Capital Management, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
8:06 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:09 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:21 AM | Werewolf Therapeutics (Filer)
| Form S-8 POS | |
|
08/08/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:12 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:56 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:27 PM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
6:44 PM | Lazarus Alon (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | EVNIN LUKE (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | Sherman Michael A. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Chatterjee Meeta (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:48 PM | Atkins Michael B. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:49 PM | Morrison Briggs (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:52 PM | DiRocco Derek (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:56 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:52 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13D/A | |
05/03/2024
6:05 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:10 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
6:16 AM | Werewolf Therapeutics (Filer)
| Form DEF 14A | |
04/12/2024
6:17 AM | Werewolf Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024
6:18 AM | Werewolf Therapeutics (Filer)
| Form ARS | |
03/07/2024
6:22 AM | Werewolf Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:11 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
6:15 AM | Werewolf Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
4:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13D/A | |
02/13/2024
5:58 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:39 PM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
3:35 PM | Werewolf Therapeutics (Filer)
| Form 424B5 | |
01/08/2024
7:08 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:19 PM | Atkins Michael B. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:13 PM | Atkins Michael B. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G | |
